Regencell Bioscience Holdings Ltd (RGC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
| 06-2016 | 03-2016 | 12-2015 | 09-2015 | 06-2015 | |
| Sales | 785,900 | 787,100 | 848,200 | 725,000 | 862,800 |
| Cost of Goods | 308,900 | 306,300 | 326,600 | 271,500 | 349,100 |
| Gross Profit | 477,000 | 480,800 | 521,600 | 453,500 | 513,700 |
| Operating Expenses | 401,300 | 400,500 | 420,300 | 402,100 | 398,700 |
| Operating Income | 76,600 | 80,600 | 101,900 | 51,900 | 115,100 |
| Interest Expense | 32,300 | 32,500 | 33,100 | 33,300 | 33,200 |
| Other Income | 11,800 | 22,300 | 22,400 | 17,700 | 5,600 |
| Pre-tax Income | 56,100 | 70,400 | 91,200 | 36,300 | 87,500 |
| Income Tax | 22,500 | 29,700 | 36,200 | 14,400 | 34,200 |
| Net Income Continuous | 33,600 | 40,700 | 55,000 | 21,900 | 53,300 |
| Minority Interests | 100 | N/A | N/A | N/A | -100 |
| Net Income | $33,500 | $40,700 | $55,000 | $21,900 | $53,400 |
| EPS Basic Total Ops | 0.21 | 0.26 | 0.36 | 0.14 | 0.34 |
| EPS Basic Continuous Ops | 0.22 | 0.26 | 0.35 | 0.14 | 0.34 |
| EPS Diluted Total Ops | 0.21 | 0.26 | 0.35 | 0.14 | 0.34 |
| EPS Diluted Continuous Ops | 0.21 | 0.26 | 0.35 | 0.14 | 0.34 |
| EPS Diluted Before Non-Recurring Items | 0.23 | 0.27 | N/A | N/A | N/A |
| EBITDA(a) | $134,700 | $137,600 | $159,000 | $105,900 | $170,400 |